STRS Ohio’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

STRS Ohio’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,300	Closed	-$73K	–	2372
2020 Q3	$73K	Sell	12,300 -27,200	-69%	-$135K	﹤0.01%	1906
2020 Q2	$203K	Buy	+39,500	New	+$249K	﹤0.01%	1639

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

STRS Ohio's AVEO Position: Q4 2020 in Review

STRS Ohio sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2020, closing a stake of 12,300 shares — an estimated $73K sold.

STRS Ohio first reported a position in AVEO in Q2 2020 and held it in 2 quarters. The position peaked at $203K in Q2 2020. 65 funds tracked by Wall St. Rank hold AVEO as of Q4 2020.

STRS Ohio reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 12,300 AVEO Pharmaceuticals, Inc. shares in Q4 2020, an estimated $73K.
STRS Ohio first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2020 and held it in 2 quarters.
STRS Ohio's AVEO Pharmaceuticals, Inc. position peaked at $203K in Q2 2020.
65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.